Forty dollars a month. That's the ceiling my neighbor Vernon Ashby set for himself years ago on anything he can't hold, taste, or return. Cross it, he says, and a company is betting you won't bother running the math. NeuroPrime blows past Vernon's ceiling by more than four times over, and for the first couple weeks of testing it against cheaper brain-health options, I figured he had the stronger argument.
Quick disclosure before we go any further, since we're already talking dollars: some of the links below are affiliate links, meaning I earn a commission if you buy through them at no extra cost to you. Everything I say about cognitive-function scores here comes out of my own supplement-tracking spreadsheet — my own little nootropics-review operation, not a lab — and I'm not a doctor or a neuroscientist, just a retired numbers guy. Talk to an actual professional before you change your own routine.
NeuroPrime Costs Three Times More Than the Audio Options
Retail on NeuroPrime runs around $174, roughly three times what either audio track in this comparison costs, and I wanted to know whether that gap actually earns its place on the ledger, or whether it's just a fancier bottle asking for a bigger check. A price tag that high has to be offset by something: lower risk, steadier results, a real return. If not, it's just an expensive way to feel productive.
Vernon didn't stay right the whole way through, though not for the reason he expected.
Before I even opened a bottle of NeuroPrime, I'd already spent six weeks on the cheap fix: a raw kale and blueberry smoothie every weekday morning. My weekly recall numbers sat completely flat the entire time, not one point of movement in either direction. Whatever that smoothie was doing for me, it wasn't showing up in the columns that mattered.
Inside My Supplement-Tracking Setup
My actual workspace is a converted spare bedroom in our house here in Plano, set up around a desk I hauled home years back when my old accounting firm downsized its office furniture along with half the staff. One monitor stays locked on the master tracking sheet at all times; the other handles whatever research rabbit hole I've fallen into that week. A whiteboard on one wall carries a scrawl of ingredient names and question marks nobody but me could decode, and a low shelf holds the bottles I've already finished, lined up in the order I started testing them.
Longer testing stretches, like this NeuroPrime one, wear on me a little, and my neighbor Pam Godfrey has a habit of showing up with a casserole around the midpoint of any test that's dragging on, like she can smell a plateau from three houses away. I never asked her to do that. She just does.
Tracking methodology is its own whole topic — tabs, weekly resets, a scoring system I built and scrapped more than once — and I won't rebuild that entire structure here, since I've laid it out in detail elsewhere. What matters for NeuroPrime specifically is one column: verbal recall, the words that come back without a mental search, and that column moved first.
Testing the Bottle Against the Audio Alternatives
NeuroPrime showed up mid-autumn in glass heavy enough to land on the kitchen island with an actual thud, not the cheap plastic rattle I'd gotten used to from budget bottles. That weight doesn't move a single number on my sheet, but it tells you something about how a company wants to be perceived — the same way a bound audit report feels more serious than a stack of loose receipts, even when the underlying math is identical.
I've chased this particular afternoon dip before, mapped out in my 90-day data audit on afternoon fog, and NeuroPrime turned out to be a different animal from anything in that earlier round.
On my walks through Klyde Warren Park downtown, the shift wasn't dramatic. Individual leaves stood out instead of a green blur, more like somebody had quietly adjusted the focus ring on an old camera than any kind of jolt. The clearer marker came on a Saturday around week eight: I finished the crossword in under fifteen minutes, no clue looked up, answers arriving instead of getting chased down. I'm careful not to oversell that one Saturday — some of an early bump is probably plain placebo baseline, the kind any new bottle can produce, and I don't have a clean way to strip that part out of the number.
I'd also been running The Brain Song and The Genius Song as lower-cost alternatives, mostly to see if sound could do anything close to what a capsule regimen does without a recurring monthly bill. Call it the unconventional line item on the ledger.
The The Brain Song sits at an accessible price point under $55, a one-time purchase rather than a recurring cost, and I compared cost-per-focused-hour between it and NeuroPrime across a few different work weeks. The long version of that comparison lives in The Brain Song Review: My Data-Backed Verdict, if you want the full breakdown.
Labels promise more than any label can prove, and the gap between what a bottle claims and what my spreadsheet actually shows has become its own recurring lesson. The audio helped in the moment — a focused hour here, a cleaner work session there — but it didn't build the kind of steady baseline I started seeing with a daily capsule routine like Neuro-Thrive or NeuroPrime. Think of it as a high-yield savings account against a long-term fund: one gives a quick bump, the other compounds slowly if it compounds at all.
The Morning My Own Spreadsheet Caught Me
One frustrating morning, well into the trial, I lost three hours to a broken VLOOKUP formula that threw an error no matter how many times I rebuilt it. It turned out I'd misspelled "NeuroPrime" in a header cell two weeks earlier, and every downstream row had been quietly failing to match ever since. The software wasn't broken. The operator was foggy that particular morning, and the operator was me, which is its own kind of humbling when tracking your own sharpness is the whole point of the exercise.
Vernon Ashby has an informal test of his own running two blocks over, and he checks in on mine every so often at the mailbox. He's deeply skeptical of anything priced over forty dollars a month, and he wasn't shy about pointing out that Neuro-Thrive gets him most of the way there for less. He's not entirely wrong about that either.
Comparing the Four Options Side by Side
Here's how my tracking sheet stacks these four up after this round of testing, cost against what I actually noticed:
| Product | Format | Primary Result Observed | Relative Cost |
|---|---|---|---|
| NeuroPrime | Capsule | Steady daily baseline, slower to show up | High / Premium |
| The Brain Song | Audio | Immediate task-focused concentration | One-time / Low |
| The Genius Song | Audio | Easier entry into a working flow state | One-time / Low |
| Neuro-Thrive | Capsule | Consistent daily energy, no jitters | Moderate |
Does the Premium Price Earn Its Cost?
By the end of this round, NeuroPrime was still the priciest line on the sheet by a wide margin, but the consistency it produced beat what I saw from the lower-cost options. Consistency lowers risk in my world, and if a higher price buys fewer surprises during the handful of consulting calls I still take on the side, that starts to look less like an indulgence and more like a premium on an insurance policy. I've walked the full ROI formula down to a single verdict elsewhere — monthly spend divided by the average weekly improvement in a tracked score — and won't redo the whole equation here, but the short version for NeuroPrime held up better than I expected.
Not everyone needs the top-shelf option to get a reasonable return. If NeuroPrime's cost is a real barrier for you, Neuro-Thrive is a genuinely solid middle ground — I tracked it separately in my 12-month memory log, and it holds up fine against pricier options on this list.
None of this means a bottle fixes anything by itself. You still have to audit the result, week over week, against whatever you were doing before, or you're just guessing with better packaging. My own guess, going in, would have said the cheap audio tracks were the smarter buy; my spreadsheet said something different by week eight, for whatever that's worth. If you want to see where NeuroPrime lands for you, you can find NeuroPrime here and start your own log before you decide either way.
The real lesson from this round wasn't that the expensive bottle wins, or that Vernon's forty-dollar rule is wrong. It's that price alone, high or low, never tells you what you're actually getting — only the tracking does. Keep a log, however simple, before you hand your money to anybody's ledger but your own.